home / stock / tcon / tcon short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 458,436 |
Total Actual Volume | 2,087,795 |
Short Trends | |
---|---|
Cover Days | 7 |
Short Days | 5 |
No Change Days | 8 |
Averages | |
---|---|
Average Short Volume | 22,922 |
Average Short Percentage | 37.22% |
Is there a TCON Short Squeeze or Breakout about to happen?
See the TCON Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-30 | 1.99 | 2 | 2 | 1.95 | 16,888 | 2,754 | 54.4807 |
2022-06-29 | 1.96 | 2.02 | 2.02 | 1.91 | 43,427 | 3,864 | 16.1938 |
2022-06-28 | 1.95 | 1.98 | 2.1 | 1.9 | 158,453 | 49,190 | 49.7920 |
2022-06-27 | 1.67 | 1.9 | 1.91 | 1.65 | 165,355 | 36,705 | 57.9117 |
2022-06-24 | 1.58 | 1.67 | 1.79 | 1.51 | 523,837 | 146,143 | 55.4884 |
2022-06-23 | 1.33 | 1.39 | 1.4099 | 1.33 | 76,141 | 10,816 | 37.8526 |
2022-06-22 | 1.36 | 1.34 | 1.4249 | 1.33 | 61,649 | 3,156 | 14.6050 |
2022-06-21 | 1.34 | 1.39 | 1.44 | 1.34 | 132,256 | 16,290 | 23.0867 |
2022-06-16 | 1.37 | 1.31 | 1.37 | 1.2434 | 62,286 | 3,729 | 11.2157 |
2022-06-15 | 1.33 | 1.34 | 1.4195 | 1.31 | 66,015 | 8,172 | 19.8388 |
2022-06-14 | 1.27 | 1.3 | 1.32 | 1.2553 | 92,097 | 18,008 | 45.3260 |
2022-06-13 | 1.45 | 1.32 | 1.45 | 1.31 | 80,033 | 15,457 | 39.3889 |
2022-06-09 | 1.51 | 1.43 | 1.5499 | 1.43 | 87,527 | 37,266 | 60.4624 |
2022-06-08 | 1.48 | 1.51 | 1.51 | 1.48 | 44,924 | 7,553 | 39.6088 |
2022-06-06 | 1.6 | 1.48 | 1.65 | 1.46 | 158,936 | 43,041 | 49.7262 |
2022-06-03 | 1.61 | 1.6 | 1.6378 | 1.58 | 44,684 | 14,581 | 54.9335 |
2022-06-02 | 1.65 | 1.6 | 1.65 | 1.6 | 105,334 | 9,534 | 23.2815 |
2022-06-01 | 1.7 | 1.65 | 1.72 | 1.64 | 30,342 | 1,951 | 13.7008 |
2022-05-31 | 1.83 | 1.72 | 1.83 | 1.66 | 71,489 | 13,809 | 35.7357 |
2022-05-26 | 1.79 | 1.8 | 1.8374 | 1.785 | 66,122 | 16,417 | 41.7948 |
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
NASDAQ Market:
TRACON Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform ...
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platf...